Xiaoyun D. Zhang

Chengdu, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications

Salvage resection for FGFR2 fusion-positive intrahepatic cholangiocarcinoma after pemigatinib therapy: a case report and literature review.

Salvage resection for FGFR2 fusion-positive intrahepatic cholangiocarcinoma after pemigatinib therapy: a case report and literature review.

Journal: Frontiers in oncology
Published: January 29, 2026

Otitis externa due to allergic contact dermatitis to earphones and earplugs: A case control study.

Otitis externa due to allergic contact dermatitis to earphones and earplugs: A case control study.

Journal: JAAD international
Published: December 22, 2025

Modeling the beating degree of wheat straw biochemical mechanical pulp using multifactorial equations.

Modeling the beating degree of wheat straw biochemical mechanical pulp using multifactorial equations.

Journal: PloS one
Published: July 28, 2025

Conversion Resection or Direct Resection for Patients with Intermediate-Stage Hepatocellular Carcinoma: A Multicentre Study.

Conversion Resection or Direct Resection for Patients with Intermediate-Stage Hepatocellular Carcinoma: A Multicentre Study.

Journal: Liver cancer
Published: May 13, 2025

Assessment of Survival Benefits Derived from Surgical Resection Subsequent to the Attainment of Complete Response upon Triple Therapy in Hepatocellular Carcinoma: A Multicenter Study.

Assessment of Survival Benefits Derived from Surgical Resection Subsequent to the Attainment of Complete Response upon Triple Therapy in Hepatocellular Carcinoma: A Multicenter Study.

Journal: Liver cancer
Published: January 19, 2025

Predicting depression using serum perfluoroalkyl and polyfluoroalkyl substances levels via interpretable machine learning.

Predicting depression using serum perfluoroalkyl and polyfluoroalkyl substances levels via interpretable machine learning.

Journal: Journal of affective disorders
Published: January 10, 2025

Adjuvant Lenvatinib for High-Risk CNLC IIb/IIIa Hepatocellular Carcinoma After Curative Hepatectomy: A Prospective Exploratory Study.

Adjuvant Lenvatinib for High-Risk CNLC IIb/IIIa Hepatocellular Carcinoma After Curative Hepatectomy: A Prospective Exploratory Study.

Journal: Journal of hepatocellular carcinoma
Published: January 08, 2025

Association between BMI and asthma in adults over 45 years of age: analysis of Global Burden of Disease 2021, China Health and Retirement Longitudinal Study, and National Health and Nutrition Examination Survey data.

Association between BMI and asthma in adults over 45 years of age: analysis of Global Burden of Disease 2021, China Health and Retirement Longitudinal Study, and National Health and Nutrition Examination Survey data.

Journal: EClinicalMedicine
Published: November 12, 2024

Lenvatinib plus transarterial chemoembolization and PD-1 inhibitors as conversion therapies for unresectable intermediate-advanced hepatocellular carcinoma: a phase 2 trial and exploratory biomolecular study.

Lenvatinib plus transarterial chemoembolization and PD-1 inhibitors as conversion therapies for unresectable intermediate-advanced hepatocellular carcinoma: a phase 2 trial and exploratory biomolecular study.

Journal: Signal transduction and targeted therapy
Published: November 03, 2024

Prediction of Pathologic Response in Unresectable Hepatocellular Carcinoma After Downstaging with Locoregional and Systemic Combination Therapy.

Prediction of Pathologic Response in Unresectable Hepatocellular Carcinoma After Downstaging with Locoregional and Systemic Combination Therapy.

Journal: Journal of hepatocellular carcinoma
Published: October 23, 2024

Comparison of Efficacy between Lenvatinib and Bevacizumab in Combination of Immune Checkpoint Inhibitor and Interventional Triple Therapy in Chinese Advanced Hepatocellular Carcinoma: The CLEAP 2302 Study.

Comparison of Efficacy between Lenvatinib and Bevacizumab in Combination of Immune Checkpoint Inhibitor and Interventional Triple Therapy in Chinese Advanced Hepatocellular Carcinoma: The CLEAP 2302 Study.

Journal: Liver cancer
Published: October 12, 2024

Identification of SOX9-related prognostic DEGs and a prediction model for hepatitis C-induced early-stage fibrosis.

Identification of SOX9-related prognostic DEGs and a prediction model for hepatitis C-induced early-stage fibrosis.

Journal: Gene
Published: August 29, 2024
Showing 1-12 of 58

Last Updated: 09/26/2026